NASDAQ:MRKR   Marker Therapeutics, Inc.
Saw this call on wallstreetbets yesterday and it looks like a very interesting call. Read more here:

Summary for TLDR: Their CEO guys bought a ton of stocks recently and they are into experimental cancer drugs. So maybe there is something on the horizon. If you zoom out on the monthly it has an obscene dilution similar to VISL. Go apes go.

Up 40% not bad

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.